Adaptive Biotechnologies Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Adaptive Biotechnologies Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10377
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company’s product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories for conducting research in the areas cancers and other immune-mediated diseases. Adaptive develops assays for both clinical diagnosis and therapeutic monitoring for a variety of disorders and conditions. The company translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. It works in partnership with institutions and biopharmaceutical companies. The company has offices in South San Francisco, San Diego and New York. Adaptive is headquartered in Seattle, Washington, the US.

Adaptive Biotechnologies Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Adaptive Biotechnologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Adaptive Biotechnologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Adaptive Biotechnologies Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Sequenta Raises Funds through Venture Financing 10
Sequenta Raises US$20 Million In Series C Financing 11
Sequenta Raises US$8.5 Million In Venture Financing 12
Partnerships 13
Sequenta Enters Into Licensing Agreement With iRepertoire 13
Adaptive Biotechnologies Enters into Agreement with Sanofi 14
Adaptive Biotech Partners with Microsoft 15
Adaptive Biotechnologies Enters into Agreement with Amgen for Multiple Myeloma 16
Adaptive Biotech Enters into Partnership with Janssen Biotech 17
Adaptive Biotech Enters into Agreement with Amgen 18
Argos Therapeutics Enters into Research Agreement with Adaptive Biotechnologies 19
Propanc Health Enters into Research Agreement with Adaptive Biotech 20
Sequenta Enters into Agreement with Illumina to Commercialize In Vitro Diagnostic Kit 21
Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 22
Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb 23
Acquisition 24
Adaptive Biotech Acquires Sequenta 24
Adaptive Biotechnologies Corp – Key Competitors 25
Adaptive Biotechnologies Corp – Key Employees 26
Adaptive Biotechnologies Corp – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Corporate Communications 28
Feb 13, 2018: Adaptive Biotechnologies Appoints Veteran Molecular Diagnostics Executive Michael Pellini, MD, to Board of Directors 28
Jul 27, 2017: Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting 29
Product News 30
Apr 03, 2017: Adaptive Biotechnologies Publishes Ground-Breaking Proof-of-Principle Experiment in Nature Genetics 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Adaptive Biotechnologies Corp, Medical Equipment, Key Facts 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Adaptive Biotechnologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Adaptive Biotechnologies Corp, Deals By Market, 2012 to YTD 2018 8
Adaptive Biotechnologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sequenta Raises Funds through Venture Financing 10
Sequenta Raises US$20 Million In Series C Financing 11
Sequenta Raises US$8.5 Million In Venture Financing 12
Sequenta Enters Into Licensing Agreement With iRepertoire 13
Adaptive Biotechnologies Enters into Agreement with Sanofi 14
Adaptive Biotech Partners with Microsoft 15
Adaptive Biotechnologies Enters into Agreement with Amgen for Multiple Myeloma 16
Adaptive Biotech Enters into Partnership with Janssen Biotech 17
Adaptive Biotech Enters into Agreement with Amgen 18
Argos Therapeutics Enters into Research Agreement with Adaptive Biotechnologies 19
Propanc Health Enters into Research Agreement with Adaptive Biotech 20
Sequenta Enters into Agreement with Illumina to Commercialize In Vitro Diagnostic Kit 21
Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 22
Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb 23
Adaptive Biotech Acquires Sequenta 24
Adaptive Biotechnologies Corp, Key Competitors 25
Adaptive Biotechnologies Corp, Key Employees 26
Adaptive Biotechnologies Corp, Subsidiaries 27

List of Figures
Adaptive Biotechnologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Adaptive Biotechnologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Adaptive Biotechnologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Adaptive Biotechnologies Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Adaptive Biotechnologies Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dillard’s Inc:戦略・SWOT・企業財務分析
    Dillard's Inc - Strategy, SWOT and Corporate Finance Report Summary Dillard's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • Amgen Inc (AMGN):企業の財務・戦略的SWOT分析
    Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bausch & Lomb Inc:企業の戦略的SWOT分析
    Bausch & Lomb Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • China Development Bank:企業の戦略・SWOT・財務情報
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • H&R Block, Inc.:戦略・SWOT・企業財務分析
    H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report Summary H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • AFGlobal Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary AFGlobal Corp (AFGlobal), formerly Ameriforge Group Inc is an engineering service provider that offers manufacturing, technology and precision engineering services. The company's services comprise forging, welding, machining, heat treat, fabrication and assembly, and testing and inspection. …
  • Les Laboratoires Servier SAS:企業の戦略的SWOT分析
    Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • NutriSystem Inc:企業の戦略的SWOT分析
    NutriSystem Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Intralytix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Intralytix Inc (Intralytix) is a biotechnology company that develops, produces and markets bacteriophage based products to control bacterial pathogens. The company offers food safety products, pet food safety products and pre-harvest interventions. Its food safety products include listshield …
  • Brunel International NV (BRNL):企業の財務・戦略的SWOT分析
    Brunel International NV (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Barkan Wine Cellars Ltd:企業の戦略的SWOT分析
    Barkan Wine Cellars Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • The Howa Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Howa Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Howa Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Torm Plc (TRMD A):企業の財務・戦略的SWOT分析
    Torm Plc (TRMD A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • FirstEnergy Corp (FE):電力:M&Aディール及び事業提携情報
    Summary FirstEnergy Corp. (FirstEnergy) is a diversified energy company, which generates, transmits, distributes and sells electricity. The company’s regulated distribution companies form one of the nation's largest investor-owned electric systems. Its major electricity generating assets include coa …
  • Akebia Therapeutics Inc (AKBA):製薬・医療:M&Aディール及び事業提携情報
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析
    Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Thermalin Diabetes LLC-製薬・医療分野:企業M&A・提携分析
    Summary Thermalin Diabetes LLC (Thermalin) is an insulin analogs developer. The company develops concentrated insulin analog for the treatment of individuals with insulin resistance and for use in miniature insulin pumps. It develops both molecular and formulation strategies to produce an acting ana …
  • HCR ManorCare Inc:企業の戦略・SWOT・財務情報
    HCR ManorCare Inc - Strategy, SWOT and Corporate Finance Report Summary HCR ManorCare Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆